LIVE: Novo Nordisk CEO Testifies on Rising Ozempic & Wegovy Prices

Watch live as Novo Nordisk CEO Lars Jergensen testifies before Congress regarding the skyrocketing prices of Ozempic and Wegovy, the company's popular diabetes and weight loss drugs.

As lawmakers question the CEO on the impact of these price hikes, this testimony could shape the future of drug pricing in the U.S. Join us at 10am ET for live coverage of this critical discussion.